Navigation Links
Human Genome Sciences to Sponsor Conference Call to Discuss First Quarter 2009 Financial Results
Date:4/22/2009

f the Securities Exchange Act of 1934, as amended. The forward-looking statements are based on Human Genome Sciences' current intent, belief and expectations. These statements are not guarantees of future performance and are subject to certain risks and uncertainties that are difficult to predict. Actual results may differ materially from these forward-looking statements because of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing of clinical trials, the Company's ability to develop and commercialize products, its dependence on collaborators for services and revenue, its substantial indebtedness and lease obligations, its changing requirements and costs associated with facilities, intense competition, the uncertainty of patent and intellectual property protection, the Company's dependence on key management and key suppliers, the uncertainty of regulation of products, the impact of future alliances or transactions and other risks described in the Company's filings with the Securities and Exchange Commission. In addition, while the Company has begun shipment of ABthrax to the U.S. Strategic National Stockpile, the Company will continue to face risks related to acceptance of future shipments and FDA's approval of the Company's Biologics License Application for ABthrax, if and when it is submitted. If the Company is unable to meet requirements associated with the ABthrax contract, future revenues from the sale of ABthrax to the U.S. Government will not occur. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. Human Genome Sciences undertakes no obligation to update or revise the information contained in this announcement whether as a result of new information, future events or circumstances or otherwise.


'/>"/>
SOURCE Human Genome Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. The Journal of Cardiac Failure Publishes Results From Celladon Corporations First-in-Human Phase 1/2 Clinical Trial in Advanced Heart Failure
2. ArunA Biomedical Announces Commercial Release of its Human Embryonic Stem Cell Derived Mesenchymal Cells
3. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Citi Conference
4. Human Genome Sciences and Morphotek(R), Inc. Announce Collaboration to Discover, Develop and Commercialize Antibodies for Oncology and Immunology
5. ArunA Biomedical, Inc. Announces Alliance with Neuromics for Distribution of Normal Human Neural Cells
6. Proteomics Study Reveals That Genes Involved in Invertebrate Longevity Have Surprising Parallels in Humans.
7. IEEE Celebrates Its 125th Anniversary Presenting Emerging, World Changing Technologies During Its Embracing Human Technology Interactions Media Event
8. Human Genome Sciences to Sponsor Conference Call
9. Human Genome Sciences to Sponsor Conference Call to Discuss Full Year 2008 Financial Results
10. Human Genome Sciences to Receive $9 Million Milestone Payment Related to GlaxoSmithKline Initiation of Phase 3 Clinical Trial of Syncria(R) in Type 2 Diabetes
11. China Biologic Products High-Purity Human Albumin Research and Development Project to be Listed in the National Torch Plan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... San Diego, California (PRWEB) July 23, 2014 ... per second in HD resolution for more than 15 minutes, ... cameras to the world of high speed imaging. “Finally, a ... any other camera we use in our everyday lives.” proclaims ... goal at Fastec has always been to demystify and simplify ...
(Date:7/23/2014)... 23, 2014 Adult stem cells ... are biological, but not magical. However, many ... treat them as if they were magical. , ... studies that constitute “stem cell tourism,” are evaluating ... to developing new regenerative medicine therapies. In reality, ...
(Date:7/22/2014)... -- The Board of Directors of BD (Becton, Dickinson and ... dividend of 54.5 cents per common share payable on September ... The indicated annual dividend rate is $2.18 per share. ... medical technology company that partners with customers and stakeholders to ... needs. Our innovative solutions are focused on improving drug delivery, ...
(Date:7/22/2014)... in water with ultrasound and they,ll spin around their ... yet knows exactly. But researchers at the National Institute ... it,s fast. At up to 150,000 revolutions per minute, ... object submerged in liquid ever reported. , The discovery ... that they could be used not only for moving ...
Breaking Biology Technology:Fastec Imaging Introduces the First High Speed Camcorder 2Fastec Imaging Introduces the First High Speed Camcorder 3The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 2The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 3The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 4The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 5NIST shows ultrasonically propelled nanorods spin dizzyingly fast 2
... Part I of this series on e-discovery, ... Civil Procedure, which require parties to address and resolve ... Without a plan of attack or a system of ... unnecessarily be placing your company at risk. This ...
... - In an effort to revive Legislative support for his ... Republican skeptics, suggesting that GOP lawmakers are paying lip service ... manufacturers, and entrepreneurs. , ,Doyle, in his most pointed remarks ... than 100,000 tons of biomass resources and would benefit from ...
... controls is clearly in the hands of people. While ... in an effort to reduce testing efforts and maximize ... people. , ,Investing in your people and culture, which ... safest bet to avoid material weaknesses and gain cost ...
Cached Biology Technology:Finding Safe Harbor in a sea of electronic discovery 2Finding Safe Harbor in a sea of electronic discovery 3Technology helps but the best way to reduce Sarbox cost is with people 2Technology helps but the best way to reduce Sarbox cost is with people 3Technology helps but the best way to reduce Sarbox cost is with people 4
(Date:7/23/2014)... million people around the world have no access to ... (WHO), 3.4 million people die from water-related diseases every ... of making a contribution to solving this problem. Working ... head of the Functional Materials Laboratory, the 23-year-old spent ... prototype. , "What makes our DrinkPure filter unique is ...
(Date:7/23/2014)... , July 23, 2014 ... threat detection, announced today it has been named in ... The Market Guide replaces Gartner,s well-known Magic Quadrant for ... categorized BioCatch as one of several vendors to deliver ... analysis will become a standard feature of at least ...
(Date:7/23/2014)... HOLE, MA -- What do mollusks, starfish, and ... marine habitat, they are all calcifiersorganisms that use ... skeletons and shells for stability and protection. , ... , published by the Marine Biological Laboratory, addresses ... composition changes worldwide. , As atmospheric carbon dioxide ...
Breaking Biology News(10 mins):ETH student develops filter for clean water around the world 2BioCatch Featured in Gartner's 2014 Online Fraud Detection Market Guide 2BioCatch Featured in Gartner's 2014 Online Fraud Detection Market Guide 3Calcification in changing oceans explored in special issue of The Biological Bulletin 2
... 2010 -- Managing diabetes in a child requires a careful ... supplies, such as needles and testing strips, adds a financial ... to be published in The Journal of Pediatrics, ... of diabetes management increases a child,s risk of being hospitalized ...
... GAINESVILLE, Fla. Habitat destruction and species extinction may ... other species, according to a paper in the journal ... In the paper to be published Thursday, UF biology professor ... studies from a wide range of systems, including data from ...
... found in southeastern waters, more than 25 percent are considered ... Fisheries and Wildlife Sciences in Virginia Tech,s College of Natural ... keynote address at the Southeastern Fishes Council annual meeting in ... meeting was "Got Water? At the Crossroads of Fish Conservation ...
Cached Biology News:New study calls for greater awareness of food supply for children with diabetes 2UF expert: Biodiversity loss correlates with increases in infectious disease 2Poor stream health imperils fish 2
FITC~Bovine Serum Albumin...
... Ambion's custom siRNA service provides the premium ... silencing research. Custom siRNAs can be readily ... base target sequence, or by providing the ... out Ambion's Silencer Validated and Silencer Pre-designed ...
, Premium quality synthesis and purification , You provide the sequence, we'll do the rest , Rigorous quality control , Your choice of purification method, amount and format , Available annealed...
Ready for formulation or direct injection into animals Provided in convenient 100, 250, 1000 and 10,000 nmol sizes HPLC purified, salt free, sterile filtered, and endotoxin tested ...
Biology Products: